Hercules Capital, Inc. (HTGC) - 2017 Form 10-K Summary
Business Context and Reporting Period
This summary covers the fiscal year ended December 31, 2017. Hercules Capital, Inc. is an internally managed, non-diversified, closed-end investment company regulated as a Business Development Company (BDC) and a Regulated Investment Company (RIC). The company focuses on providing senior secured loans, primarily structured debt with warrants, to high-growth, venture capital-backed companies in technology, life sciences, and sustainable/renewable technology sectors. As of December 31, 2017, the company held approximately $1.54 billion in total investments.
Key Financial Metrics
| Metric | 2017 Value | 2016 Value |
|---|---|---|
| Total Assets | $1,654.7 million | $1,464.2 million |
| Total Net Assets | $841.0 million | $787.9 million |
| Net Asset Value (NAV) per Share | $9.96 | $9.90 |
| Total Investment Income | $190.9 million | $175.1 million |
| Net Investment Income | $96.4 million | $100.3 million |
| Net Realized Gain/(Loss) | ($26.7 million) | $4.6 million |
| Net Change in Unrealized Appreciation | $9.3 million | ($36.2 million) |
| Net Increase in Net Assets from Operations | $79.0 million | $68.7 million |
| Operating Expenses | $94.4 million | $82.7 million |
| Weighted Average Cost of Debt | 5.9% | 5.8% |
| Asset Coverage Ratio (Excl. SBA) | 236.7% | 226.5% (implied) |
| Unfunded Commitments | $73.6 million | $59.7 million |
Material Changes vs. Prior Period
- Portfolio Growth: Total investment portfolio value increased by approximately $118 million (8.3%) year-over-year, driven by new fundings of $764.8 million. The debt portfolio grew to $1.42 billion.
- Realized Losses: The company recognized a net realized loss of $26.7 million in 2017, a significant shift from the $4.6 million net realized gain in 2016. This was primarily due to write-offs of debt and equity investments in five portfolio companies and liquidation losses, offset by gains from the sale of five other investments.
- Unrealized Appreciation: The portfolio recorded $9.3 million in net unrealized appreciation in 2017, reversing the $36.2 million depreciation seen in 2016. This improvement was largely due to the reversal of prior period collateral-based impairments on four portfolio companies.
- Debt Structure: The company issued $230.0 million in 2022 Convertible Notes and $150.0 million in 2022 Notes. It also redeemed $110.4 million of 2019 Notes and $75.0 million of 2024 Notes. Total outstanding borrowings were approximately $802.9 million.
- Portfolio Grading: The weighted average investment grading improved to 2.17 in 2017 from 2.41 in 2016, reflecting upgrades in credit quality and the conversion of distressed debt positions to equity.
Guidance, Outlook, and Risks
Management Commentary: Management highlighted a strong origination pipeline with $122.0 million in non-binding term sheets. The company maintains a variable distribution policy targeting 90-100% of taxable quarterly income. A quarterly distribution of $0.31 per share was declared in February 2018.
Risks and Contingencies:
- Concentration Risk: The portfolio is concentrated in technology-related sectors. The top five industries (Drug Discovery, Software, Internet Services, Media, Renewable Tech) comprised 74.9% of the portfolio. Seven individual investments represented over 5% of net assets each.
- Liquidity and Leverage: The company relies on debt financing (SBA debentures, senior notes, credit facilities) to leverage returns. While the asset coverage ratio (236.7% excluding SBA) is well above the 200% regulatory minimum, a decline in asset values could restrict borrowing capacity and dividend distributions.
- Interest Rate Risk: Approximately 96.4% of the debt portfolio is at floating rates. While this positions the company to benefit from rising rates, it also increases the cost of funds and the risk of borrower default if rates rise significantly.
- Valuation Uncertainty: Approximately 93.2% of assets are Level 3 investments (private companies) valued in good faith by the Board. These valuations are subject to significant judgment and may differ from realized values.
- Regulatory Compliance: As a BDC and RIC, the company must maintain specific asset coverage ratios and distribution requirements to avoid corporate-level taxation. Failure to meet these could result in significant tax liabilities.
Key Facts for Investor Verification
- NAV vs. Market Price: Verify the current trading price of HTGC relative to the reported NAV of $9.96 to assess the discount/premium.
- Realized Loss Drivers: Review the specific details of the five portfolio companies written off in 2017 to understand the nature of the credit losses.
- Debt Maturity Profile: Confirm the maturity schedule of the $802.9 million in outstanding debt, particularly the 2022 Notes and Convertible Notes, to assess refinancing risks.
- Unfunded Commitments: Monitor the $73.6 million in unfunded commitments to ensure sufficient liquidity is available for future drawdowns.
- Dividend Sustainability: Compare the $0.31 quarterly distribution against the Net Investment Income of $96.4 million to verify coverage and sustainability.